Delivery Order SPE2DE21D7010-SPE2D626F10W8
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $5,204.05 on November 14, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is for the supply of LEVERAGE LFS spinal medical devices and related surgical instruments, with performance to be completed by December 5, 2025, at Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $3,650.98 fixed-price delivery order with economic price adjustment (Contract No. 4570280058, "ARCHON DEGENERATIVE") by the Defense Logistics Agency Medical Supply Chain on November 26, 2025. The delivery order, with a completion date of January 5, 2026, represents a competitive open-market procurement without set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,839.63 for allograft products on November 25, 2025, with an ultimate completion date of December 23, 2025. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies and equipment...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order for allograft products valued at $1,685.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of January 2, 2026. This award was made through open market...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 26, 2025, for the MAXCESS spinal surgical product line. The contract, which is structured as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of January 5, 2026, and will be performed at Nuvasive's San Diego, California...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., received a delivery order award valued at $8,138.78 from the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of January 2, 2026. This fixed-price delivery order with economic price adjustment pricing will be fulfilled at Nuvasive's San Diego facility and involves the supply of LEVERAGE LFS spinal medical devices and related surgical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 on May 28, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as delivery order 4568393753 for the SMALL INTERLOCK II product, is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of June 17, 2025. This award was made without any set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $4,346 fixed-price delivery order with economic price adjustment (FPEA) by the Defense Logistics Agency (DLA) Medical Supply Chain on November 26, 2025, with a completion date of January 5, 2026. This delivery order, issued without set-aside designation, represents a competitive open-market procurement for specialized spinal surgical products and services to support...
- Nuvasive, Inc. was awarded a $21,488.67 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency, on April 29, 2025. The delivery order, which is not set-aside designated, requires completion by May 19, 2025, and will be performed in San Diego, California. As a leading medical device manufacturer specializing in spinal surgery products, Nuvasive supplies advanced spinal implants, fusion devices,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F10W8Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, has been awarded a fixed-price delivery order valued at $2,453.05 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The delivery order, designated as contract 4570253546 for the ATTRAX product line, represents a specialized spinal surgical technology component within the government's broader medical supply procurement strategy. Performance will be completed by January 2, 2026, and will be conducted at Nuvasive's San Diego, California facility. This award carries no set-aside designation, reflecting the company's successful competition in open market federal procurements serving the Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued against a larger strategic procurement vehicle—an $8 million Blanket Purchase Agreement with the Defense Health Agency structured as an Indefinite Delivery/Indefinite Quantity contract effective through March 2027. The BPA enables streamlined procurement of Nuvasive's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and bone graft materials across Department of Defense and Veterans Health Administration medical facilities. Nuvasive has consistently demonstrated sustained capability as a critical supplier of orthopedic and neurosurgical technologies supporting military and veteran healthcare operations, with delivery orders typically structured as fixed-price agreements featuring economic price adjustment mechanisms to maintain cost certainty while accommodating market fluctuations in specialized medical device procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/10/25 |